Platelet serotonin uptake in drug-naïve depressive patients before and after treatment with citalopram

Psychiatry Research

Volumn 161, Issue 2, 2008, Pages 185-194

  Fišar, Zdeněk ^a   Kališová, Lucie ^a   Paclt, Ivo ^a   Anders, Martin ^a   Vevera, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Citalopram; Depression; Platelets; Serotonin uptake

Indexed keywords

CITALOPRAM; SEROTONIN;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DISTRIBUTION VOLUME; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SEROTONIN UPTAKE; SEX DIFFERENCE; THROMBOCYTE KINETICS;

ADULT; BLOOD PLATELETS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SEROTONIN; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 38549119393     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.06.022     Document Type: Article

References (69)

1. Åberg-Wistedt A., Jostell K.G., Ross S.B., and Westerlund D. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression. Psychopharmacology (Berl) 74 (1981) 297-305
2. Alvarez J.C., Gluck N., Fallet A., Gregoire A., Chevalier J.F., Advenier C., and Spreux-Varoquaux O. Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?. Psychopharmacology (Berl) 143 (1999) 97-101
3. Axelson D.A., Perel J.M., Birmaher B., Rudolph G., Nuss S., Yurasits L., Bridge J., and Brent D.A. Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents. American Journal of Psychiatry 162 (2005) 802-804
4. Balon R. Biological predictors of antidepressant treatment outcome. Clinical Neuropharmacology 12 (1989) 195-214
5. Bakish D., Cavazzoni P., Chudzik J., Ravindran A., and Hrdina P.D. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biological Psychiatry 41 (1997) 184-190
6. Baumann P. Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI). International Clinical Psychopharmacology 6 Suppl. 5 (1992) 13-20
7. Baumann P., Zullino D.F., and Eap C.B. Enantiomers' potential in psychopharmacology-a critical analysis with special emphasis on the antidepressant escitalopram. European Neuropsychopharmacology 12 (2002) 433-444
8. Beving H., Bjerkenstedt L., Malmgren R., Olsson P., and Unge G. The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patients. Journal of Neural Transmission 61 (1985) 95-104
9. Bianchi M., Moser C., Lazzarini C., Vecchiato E., and Crespi F. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Experimental Brain Research 143 (2002) 191-197
10. Bjerkenstedt L., Flyckt L., Overø K.F., and Lingjærde O. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels. European Journal of Clinical Pharmacology 28 (1985) 553-557
11. Blardi P., De Lalla A., Leo A., Auteri A., Iapichino S., Di Muro A., Dell'Erba A., and Castrogiovanni P. Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients. Journal of Clinical Psychopharmacology 22 (2002) 131-136
12. Bourdeaux R., Desor D., Lehr P.R., Younos C., and Capolaghi B. Effects of fluoxetine and norfluoxetine on 5-hydroxytryptamine metabolism in blood platelets and brain after administration to rats. Journal of Pharmacy and Pharmacology 50 (1998) 1387-1392
13. Castrogiovanni P., Blardi P., De Lalla A., Dell'Erba A., and Auteri A. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?. Psychopharmacology Bulletin 37 (2003) 102-108
14. Čičin-Šain L., Mimica N., Hranilović D., Balija M., Ljubin T., Makarić G., Folnegović-Šmalc V., and Jernej B. Posttraumatic stress disorder and platelet serotonin measures. Journal of Psychiatric Research 34 (2000) 155-161
15. 2A receptor. Journal of Neurochemistry 63 (1994) 465-469
16. Da Prada M., Cesura A.M., Launay J.M., and Richards J.G. Platelets as a model for neurones?. Experientia 44 (1988) 115-126
17. Fišar Z., Anders M., and Kališová L. Effect of pharmacologically selective antidepressants on serotonin uptake in rat platelets. General Physiology and Biophysics 24 (2005) 113-128
18. Franke L., Schewe H.-J., Müller B., Campman V., Kitzrow W., Uebelhack R., Berghöferb A., and Müller-Oerlinghausen B. Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects. Relationship between 5HT content and 5HT uptake. Life Sciences 67 (2000) 301-315
19. Franke L., Schewe H.J., Uebelhack R., Berghöfer A., and Müller-Oerlinghausen B. Platelet-5HT uptake and gastrointestinal symptoms in patients suffering from major depression. Life Sciences 74 (2003) 521-531
20. Franke L., Schewe H.-J., Uebelhack R., and Müller-Oerlinghausen B. High platelet-serotonin uptake activity is associated with a rapid response in depressed patients treated with amitriptyline. Neuroscience Letters 345 (2003) 105-108
21. Fuller R.W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sciences 55 (1994) 163-167
22. Goodnick P.J., Henry J., and Kumar A. Neurochemistry and paroxetine response in major depression. Biological Psychiatry 37 (1995) 417-419
23. Greenberg B.D., Li Q., Lucas F.R., Hu S., Sirota L.A., Benjamin J., Lesch K.-P., Hamer D., and Murphy D.L. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. American Journal of Medical Genetics 96 (2000) 202-216
24. Haase J., Killian A.-M., Magnani F., and Williams C. Regulation of the serotonin transporter by interacting proteins. Biochemical Society Transactions 29 (2001) 722-728
25. Healy D., and Leonard B.E. Monoamine transport in depression: kinetics and dynamics. Journal of Affective Disorders 12 (1987) 91-103
26. 2 receptors. Journal of Psychiatry Neuroscience 20 (1995) 11-19
27. 2A receptors unchanged by antidepressant treatment. Psychiatry Research 66 (1997) 73-85
28. Hyttel J. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology (Berl) 51 (1977) 225-233
29. 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology (Berl) 60 (1978) 13-18
30. Hyttel J., Overo K.F., and Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology (Berl) 83 (1984) 20-27
31. Jernej B., Vladić A., Čičin-Šain L., Hranilović D., Banović M., Balija M., Bilić E., Sučić Z., Vukadin S., and Grgičević D. Platelet serotonin measures in migraine. Headache 42 (2002) 588-595
32. Joyce P.R., and Paykel E.S. Predictors of drug response in depression. Archives of General Psychiatry 46 (1989) 89-99
33. Kaplan R.D., and Mann J.J. Altered platelet serotonin uptake kinetics in schizophrenia and depression. Life Sciences 31 (1982) 583-588
34. Koyama T., and Yamashita I. Biological markers of depression: WHO multi-center studies and future perspective. Progress in Neuro-Psychopharmacology & Biological Psychiatry 16 (1992) 791-796
35. Lesch K.-P., Wolozin B.L., Murphy D.L., and Riederer P.J. Primary structure of the human platelet serotonin uptake site - identity with the brain-serotonin transporter. Journal of Neurochemistry 60 (1993) 2319-2322
36. Lingjærde O. From clomipramine to mianserin: therapeutic relevance of interactions with serotonin uptake and storage, as studied in the blood platelet model. Acta Psychiatrica Scandinavica 320 (1985) 10-19 (Suppl.)
37. Malmgren R., Åberg-Wistedt A., and Mårtensson B. Aberrant seasonal variations of platelet serotonin uptake in endogenous depression. Biological Psychiatry 25 (1989) 393-402
38. 3H]-imipramine binding and serotonin uptake and concentration in major depressive disorder. Acta Psychiatrica Scandinavica 83 (1991) 125-133
39. Maurer-Spurej E., Pittendreigh C., and Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thrombosis and Haemostasis 91 (2004) 119-128
40. Mellerup E., Langer S.Z., et al. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study. Pharmacopsychiatry 23 (1990) 113-117
41. Meltzer H.Y., and Arora R.C. Platelet markers of suicidality. Annals of New York Academy of Sciences 487 (1986) 271-280
42. Meltzer H.Y., Arora R.C., Baber R., and Tricou B.J. Serotonin uptake in blood platelets of psychiatric patients. Archives of General Psychiatry 38 (1981) 1322-1326
43. 11C]DASB PET imaging study. American Journal of Psychiatry 158 (2001) 1843-1849
44. Müller-Oerlinghausen B., Roggenbach J., and Franke L. Serotonergic platelet markers of suicidal behavior-do they really exist?. Journal of Affective Disorders 79 (2004) 13-24
45. Murphy D.L. Peripheral indices of central serotonin function in humans. Annals of New York Academy of Sciences 600 (1990) 282-295
46. Neuger J., El Khoury A., Kjellman B.F., Wahlund B., Åberg-Wistedt A., and Stain-Malmgren R. Platelet serotonin functions in untreated major depression. Psychiatry Research 85 (1999) 189-198
47. Neuger J., Wistedt B., Åberg-Wistedt A., and Stain-Malmgren R. Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients. Journal of Clinical Psychopharmacology 22 (2002) 400-405
48. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., Blier P., and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 5308-5313
49. Owens M.J., and Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clinical Chemistry 40 (1994) 288-295
50. Pandey G.N., Pandey S.C., Janicak P.G., Marks R.C., and Davis J.M. Platelet serotonin-2 receptor binding sites in depression and suicide. Biological Psychiatry 28 (1990) 215-222
51. Plenge P., and Mellerup E.T. An affinity-modulating site on neuronal monoamine transport proteins. Pharmacology & Toxicology 80 (1997) 197-201
52. Plenge P., and Wiborg O. High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions. Neuroscience Letters 383 (2005) 203-208
53. Preskorn S.H. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clinical Pharmacokinetics 32 Suppl. 1 (1997) 1-21
54. Rao M.L., Frahnert C., and Zagorski O. Initial serotonin transport into viable platelets and imipramine binding to platelet membranes. Journal of Neural Transmission 109 (2002) 547-556
55. Rausch J.L. An hypothesis of initial conditions: receptor-effector systems as determinants of psychopharmacologic drug response. International Journal of Neuropsychopharmacology 1 (1998) 137-151
56. Rausch J.L., Hobby H.M., Shendarkar N., Johnson M.E., and Li J. Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis. Journal of Clinical Psychopharmacology 21 (2001) 139-142
57. Rausch J.L., Johnson M.E., Fei Y.J., Li J.Q., Shendarkar N., Hobby H.M., Ganapathy V., and Leibach F.H. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biological Psychiatry 51 (2002) 723-732
58. Rausch J.L., Moeller F.G., and Johnson M.E. Initial platelet serotonin (5-HT) transport kinetics predict nortriptyline treatment outcome. Journal of Clinical Psychopharmacology 23 (2003) 138-144
59. Rausch J.L., Johnson M.E., Li J., Hutcheson J., Carr B.M., Corley K.M., Gowans A.B., and Smith J. Serotonin transport kinetics correlated between human platelets and brain synaptosomes. Psychopharmacology (Berl) 180 (2005) 391-398
60. Sánchez C., and Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cellular and Molecular Neurobiology 19 (1999) 467-489
61. Slotkin T.A., Whitmore W.L., Dew K.L., and Kilts C.D. Uptake of serotonin into rat platelets and synaptosomes: comparative structure-activity relationships, energetics and evaluation of the effects of acute and chronic nortriptyline administration. Brain Research Bulletin 17 (1986) 67-73
62. Smeraldi E., Benedetti F., and Zanardi R. Serotonin transporter promoter genotype and illness recurrence in mood disorders. European Neuropsychopharmacology 12 (2002) 73-75
63. Sneddon J.M. Blood platelets as a model for monoamine-containing neurones. Progress in Neurobiology 1 (1973) 151-198
64. Stahl S.M. Peripheral models for the study of neurotransmitter receptors in man. Psychopharmacology Bulletin 21 (1985) 663-671
65. Stain-Malmgren R., Kjellman B.F., and Åberg-Wistedt A. Platelet serotonergic functions and light therapy in seasonal affective disorder. Psychiatry Research 78 (1998) 163-172
66. Stain-Malmgren R., Khoury A.E., Ǻberg-Wistedt A., and Tham A. Serotonergic function in major depression and effect of sertraline and paroxetine treatment. Internationa Clinical Psychopharmacology 16 (2001) 93-101
67. Stoltenberg S.F., Twitchell G.R., Hanna G.L., Cook E.H., Fitzgerald H.E., Zucker R.A., and Little K.Y. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. American Journal of Medical Genetics 114 (2002) 230-234
68. Tuomisto J., Tukiainen E., and Ahlfors U.G. Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology 65 (1979) 141-147
69. Wirz-Justice A. Platelet research in psychiatry. Experientia 44 (1988) 145-152